Advertisement

Reactions Weekly

, Volume 1633, Issue 1, pp 6–6 | Cite as

Increased risk of bladder cancer with pioglitazone?

News item
  • 32 Downloads

Reference

  1. US Food and Drug Administration. FDA Drug Safety Communication: Updated FDA review concludes that use of type 2 diabetes medicine pioglitazone may be linked to an increased risk of bladder cancer. Internet Document : 12 Dec 2016. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm519616.htm

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations